Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 01:30:00 11/05/2024 am IST 		5-day change 1st Jan Change
41.99 USD -1.25% Intraday chart for Apellis Pharmaceuticals, Inc. -11.53% -29.85%
09/05 Apellis Pharmaceuticals Insider Sold Shares Worth $3,341,848, According to a Recent SEC Filing MT
08/05 UBS Adjusts Price Target on Apellis Pharmaceuticals to $85 From $89, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
APELLIS PHARMACEUTICALS, INC. Stock Apellis Pharmaceuticals, Inc.
 5.1B -
CSL LIMITED Stock CSL Limited
 89.08B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 40.9B
BIOGEN INC. Stock Biogen Inc.
 32.25B
UCB Stock UCB
 25.14B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.39B
  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW